Vanda's Drug for Rare Disorder Meets Main Trial Goal
Vanda's drug for rare disorder meets main trial goal
Filed under: drug treatment news
(Reuters) – Vanda Pharmaceuticals Inc said a late-stage trial of its drug to treat a rare disorder affecting blind people met the main goal of showing improvement over a placebo, sending its shares up as much as 37 percent. The drug tasimelteon is …
Read more on Reuters
Brooke Mueller checks back into rehab for Adderall addiction, marking her 19th …
Filed under: drug treatment news
The troubled ex-wife of Charlie Sheen checked back into rehab Monday night to seek treatment for an addiction to Adderall, a psycho-stimulant drug commonly used for attention deficit disorder (ADD), according to TMZ. This would be the whopping 19th …
Read more on New York Daily News
Novel Drug Therapy Targets Aggressive Form of Non-Hodgkin's Lymphoma
Filed under: drug treatment news
Dec. 10, 2012 — Diffuse large B-cell lymphoma (DLBCL) is the most common subtype of non-Hodgkin's lymphoma and the seventh most frequently diagnosed cancer. The most chemotherapy resistant form of DLBCL, called activated B-cell — DLBCL …
Read more on Science Daily (press release)